“The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men With Obesity and Insulin Resistance”. Global Scientific Review 48 (February 25, 2026): 42–45. Accessed May 22, 2026. https://mail.scienticreview.com/index.php/gsr/article/view/602.